The sales are part of routine option exercises and tax planning, not broad-based insider skepticism. Monitor future Form 4 filings to see if selling continues beyond this cluster. No immediate negative signal, but the concentration of activity among top executives warrants attention.
Price Chart
Executive Summary
Four corporate insiders at United Therapeutics, including the CEO, CFO, and General Counsel, sold shares in open-market transactions over a 5-day period, realizing $1.34 million in total proceeds. These sales were part of broader option exercise and tax-related transactions, with multiple executives exercising in-the-money options and selling a portion of the resulting shares.
Key Financial Metrics
Key Facts
- CEO Martine Rothblatt sold $702,522 worth of shares over two days (248 shares on 4/17, 977 on 4/20) at prices between $572.41 and $575.38
- CFO James Edgemon sold $802,084 in shares (520 on 4/16, 880 on 4/20) following the exercise of 20,000 options
- EVP Paul Mahon sold $114,807 after exercising 8,300 options
- Director Christopher Patusky sold $578,880 following the exercise of 1,000 options
- Total open-market sales: $1.34 million; all transactions occurred between April 16–20, 2026
Financial Impact
$1.34 million in open-market sales over 5 days, representing 0.005% of market cap
Risk Factors
- Perception of insider selling could weigh on sentiment, especially given CEO participation
- If future filings show continued selling without offsetting purchases, it may signal reduced confidence
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-UTHR-1776771704367 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $500.35 $497.31 | ▼ −0.61% | ▼ −2.72% | $571.38 (+14.20%) |
Sep 11, 2026 21d ago | Insider Cluster | $497.11 $494.63 | ▼ −0.50% | ▼ −0.28% | $571.38 (+14.94%) |
Sep 10, 2026 22d ago | Insider Cluster | $503.86 $497.27 | ▼ −1.31% | ▼ −0.81% | $571.38 (+13.40%) |
Sep 9, 2026 23d ago | Insider Cluster | $506.82 $498.48 | ▼ −1.65% | ▼ −0.99% | $571.38 (+12.74%) |
Sep 4, 2026 28d ago | Insider Cluster | $487.61 $502.70 | ▲ +3.09% | ▲ +4.30% | $571.38 (+17.18%) |
Sep 3, 2026 29d ago | Insider Cluster | $488.16 $497.11 | ▲ +1.83% | ▲ +2.98% | $571.38 (+17.05%) |
Aug 28, 2026 5w ago | Insider Cluster | $515.46 $487.61 | ▼ −5.40% | ▼ −5.51% | $571.38 (+10.85%) |
Aug 27, 2026 5w ago | Insider Cluster | $527.91 $492.02 | ▼ −6.80% | ▼ −6.03% | $571.38 (+8.23%) |
Aug 26, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $571.38 (+10.59%) |
Aug 25, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $571.38 (+10.59%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access